Mortality in severe antibody deficiencies patients during the first two years of the covid-19 pandemic: vaccination and monoclonal antibodies efficacy

HIGHLIGHTS

• who: Cinzia Milito and colleagues from the Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy have published the research: Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy, in the Journal: Biomedicines 2022, 10, 1026. of 22/02/2022
• what: The aim of this paper was to assess by a longitudinal prospective study COVID-19 infection and mortality rates and disease severity in the first two years of the pandemic in a cohort of 471 Primary Antibody Defects adult patients. The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.